Sanofi Insider Trades

SNYNF

Sanofi (SNYNF) is a global pharmaceutical company known for developing medicines and vaccines in areas such as oncology, immunology, and rare diseases. Its executive leadership includes CEO Paul Hudson and Chairman of the Board Frédéric Oudéa, with François-Xavier Roger serving as Chief Financial Officer. Insider trading activity at Sanofi generally appears balanced, characterized by modest buying by directors and some stock compensation. Track insider trading activity from Sanofi executives and directors.

Trades Last 12 Months

All Insider Trades for Sanofi

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sanofi Director
Holding Value $1.76B 21,775,741 shares
Last Trade
Jul 10, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.1M 175,000 shares
$103.45
$80.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up